Table 1. General Patient Data for Nasal Swabs Used for Virus Isolation.
| Sample ID/Locality Code* | Patient Age Sex | Hospital Admission Date | Nasal Swab Date | LOS Ψ (Days) | Comorbidity | Mortality |
| 80/3 | 31/F | 9/30/2009 | 9/30/2009 | 10 | COPD, MRSA | Died |
| 96/2 | 51/M | 10/24/2009 | 10/26/2009 | 4 | BMI = 123.6 | Survived |
| 99/3 | 35/M | 10/28/2009 | 10/29/2009 | 3 | ND | Survived |
| 104/2 | 58/M | 10/30/2009 | 11/4/2009 | 2 | ND | Died |
| 108/6 | 57/F | 11/2/2009 | 11/3/2009 | 19 | ND | Survived |
| 110/6 | 54/F | 11/3/2009 | 11/4/2009 | 3 | COPD, diabetes, renal disease, BMI = 79.7 | Survived |
| 136/3 | 46/M | 12/10/2009 | 12/11/2009 | 8 | Diabetes, MRSA | Survived |
| 180/2 | 53/M | 3/24/2010 | 4/1/2010 | 19 | COPD, renal disease | Died |
| 190/2 | 55/F | 4/10/2010 | 4/15/2010 | 12 | ND | Died |
*
locality, 2 = western Kentucky (KY); 3 = eastern KY; 6 = Louisville metro;
Ψ
LOS, Length of stay in hospital; MRSA, methicillin-Resistant Staphylococcus aureus; COPD, chronic obstructive pulmonary disease; BMI- body mass index; ND, none determined.